v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 765,083 $ 551,801
Accounts receivable 31,505 7,727
Inventory 85,484 85,714
Prepaid assets 36,559 36,350
Restricted cash 1,275 1,273
Other current assets 34,349 36,658
Total current assets 954,255 719,523
Non-current assets:    
Right-of-use assets 17,854 18,747
Property and equipment, net 5,967 6,148
Other assets 793 15,799
Total assets 978,869 760,217
Current liabilities:    
Accounts payable 31,494 37,342
Accrued expenses 71,251 95,139
Current portion of development liability 30,071 29,504
Current portion of right-of-use liabilities 5,828 5,625
Total current liabilities 138,644 167,610
Long-term liabilities:    
Long-term development liability 321,713 315,647
Convertible senior notes 92,809 92,736
Right-of-use liabilities 13,233 14,352
Other liabilities 347  
Total liabilities 566,746 590,345
Stockholders' equity:    
Preferred stock, $0.0001 par value; 10,000 shares authorized, and zero shares issued and outstanding at March 31, 2023 and December 31, 2022 0 0
Common stock, $0.0001 par value; 200,000 shares authorized at March 31, 2023 and December 31, 2022; 116,179 shares issued and outstanding at March 31, 2023, and 110,772 shares issued and outstanding at December 31, 2022 12 11
Additional paid-in capital 2,899,524 2,479,596
Accumulated other comprehensive loss (775) (875)
Accumulated deficit (2,486,638) (2,308,860)
Total stockholders' equity 412,123 169,872
Total liabilities and stockholders' equity $ 978,869 $ 760,217